tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Sino Biopharmaceutical Advances LM-350 Clinical Trials in Australia
Company AnnouncementsSino Biopharmaceutical Advances LM-350 Clinical Trials in Australia
5d ago
Sino Biopharmaceutical Advances Innovative Cancer Therapy with Phase I Trial
PremiumCompany Announcements
Sino Biopharmaceutical Advances Innovative Cancer Therapy with Phase I Trial
7d ago
Sino Biopharmaceutical’s Innovative Diabetes Drug Gains Regulatory Acceptance
PremiumCompany Announcements
Sino Biopharmaceutical’s Innovative Diabetes Drug Gains Regulatory Acceptance
8d ago
Sino Biopharmaceutical Gains Approval for Groundbreaking Lung Cancer Drug in China
PremiumCompany Announcements
Sino Biopharmaceutical Gains Approval for Groundbreaking Lung Cancer Drug in China
1M ago
Sino Biopharmaceutical Advances Respiratory Drug Portfolio with Promising Study Results
PremiumCompany Announcements
Sino Biopharmaceutical Advances Respiratory Drug Portfolio with Promising Study Results
1M ago
Sino Biopharmaceutical’s Zongertinib Gains Breakthrough Designation in China
PremiumCompany AnnouncementsSino Biopharmaceutical’s Zongertinib Gains Breakthrough Designation in China
1M ago
Sino Biopharmaceutical’s LM-302 Drug Gains Breakthrough Designation in China
Premium
Company Announcements
Sino Biopharmaceutical’s LM-302 Drug Gains Breakthrough Designation in China
1M ago
Sino Biopharmaceutical Reports Strong Growth in 2025 Earnings
Premium
Company Announcements
Sino Biopharmaceutical Reports Strong Growth in 2025 Earnings
1M ago
Sino Biopharmaceutical Declares Interim Dividend for 2025
PremiumCompany Announcements
Sino Biopharmaceutical Declares Interim Dividend for 2025
1M ago
Sino Biopharmaceutical Reports Strong Interim Financial Results for 2025
PremiumCompany Announcements
Sino Biopharmaceutical Reports Strong Interim Financial Results for 2025
1M ago
Sino Biopharmaceutical’s Innovative Cancer Drug TQB3142 Gains NMPA Approval for Clinical Trials
PremiumCompany Announcements
Sino Biopharmaceutical’s Innovative Cancer Drug TQB3142 Gains NMPA Approval for Clinical Trials
2M ago
Sino Biopharmaceutical’s TQB3122 IND Application Accepted by NMPA
PremiumCompany Announcements
Sino Biopharmaceutical’s TQB3122 IND Application Accepted by NMPA
2M ago
Sino Biopharmaceutical’s Phase II Trial for Innovative Cancer Drug Approved
PremiumCompany AnnouncementsSino Biopharmaceutical’s Phase II Trial for Innovative Cancer Drug Approved
2M ago
Sino Biopharmaceutical’s Rovadicitinib Gains Breakthrough Designation for cGVHD
Premium
Company Announcements
Sino Biopharmaceutical’s Rovadicitinib Gains Breakthrough Designation for cGVHD
2M ago
Sino Biopharmaceutical’s TQC3302 Receives Clinical Trial Approval
Premium
Company Announcements
Sino Biopharmaceutical’s TQC3302 Receives Clinical Trial Approval
2M ago
Sino Biopharmaceutical: Innovation-Driven Growth and Strong Financials Justify Buy Rating
PremiumRatings
Sino Biopharmaceutical: Innovation-Driven Growth and Strong Financials Justify Buy Rating
2M ago
Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend Consideration
PremiumCompany Announcements
Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend Consideration
2M ago
Sino Biopharmaceutical to Receive $300 Million Milestone Payment from Merck Collaboration
PremiumCompany Announcements
Sino Biopharmaceutical to Receive $300 Million Milestone Payment from Merck Collaboration
2M ago
Sino Biopharmaceutical Gains FDA Approval for Innovative Cancer Drug
PremiumCompany Announcements
Sino Biopharmaceutical Gains FDA Approval for Innovative Cancer Drug
2M ago
Sino Biopharmaceutical Expands with LaNova Medicines Acquisition Update
PremiumCompany AnnouncementsSino Biopharmaceutical Expands with LaNova Medicines Acquisition Update
2M ago
Sino Biopharmaceutical Advances TQB6411 in Phase I Clinical Trials
Premium
Company Announcements
Sino Biopharmaceutical Advances TQB6411 in Phase I Clinical Trials
2M ago
Sino Biopharmaceutical Acquires Full Stake in LaNova Medicines
Premium
Company Announcements
Sino Biopharmaceutical Acquires Full Stake in LaNova Medicines
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >